Clinical Trial Update: Effect of Ultra-low Dose Naloxone During Supraclavicular Brachial Plexus Block on Post-operative Opioi [NA]

View source ↗

Summary

A completed clinical trial evaluating ultra-low dose naloxone as an adjuvant during supraclavicular brachial plexus block to affect postoperative opioid use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Extremity Trauma

Drugs mentioned

• Naloxone (Naloxone)

Snippet

Sponsor: Mansoura University | Conditions: Upper Extremity Trauma | NA | Status: COMPLETED